510(k) · Cleared
ClearedEnd Tidal CO2 Nasal Cannula
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Care Fusion · CCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase
Cleared on May 4, 2012 as substantially equivalent to K863883 (Salter Labs, 1986) and 1 other predicate after a 73-day review. Its family tree reaches back 1 generation to 1986.
- Decided
- May 4, 2012
- Review
- 73 days
- Class
- Class II
- Product code
- CCK
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K863883 (1986). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK863883 Models 4002/4102/4202 Oxy. Delivery/CO2 CannulaSalter Labs · 1986
- This deviceK120518 End Tidal CO2 Nasal CannulaCare Fusion · 2012
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K863883 | Models 4002/4102/4202 Oxy. Delivery/CO2 Cannula | Salter Labs | 1986 | — |
| 0 (this device) | K120518 | End Tidal CO2 Nasal Cannula | Care Fusion | 2012 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1989 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CCK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new CCK device
- #1 K253030 Capnostream™35 Portable Respiratory Monitor…score 15.8 · 16 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K863883 | Models 4002/4102/4202 Oxy. Delivery/CO2 CannulaSummary page 1…el 73 Anesthesiology Regulation Class 11per 21CFR §868.1400 Product Code(s) CCK Legally marketed device(s) to K863883: Models 4002/4102/4202 Oxy. Delivery/CO 2 Cannula which equivalence is claimed K892406: Modified oxygen delivery/CO 2 Sampl… | 1986 |
| * | K892406 | Modified Oxygen Delivery/CO2 Sample Nasal CannulaSummary page 1…00 Product Code(s) CCK Legally marketed device(s) to K863883: Models 4002/4102/4202 Oxy. Delivery/CO 2 Cannula which equivalence is claimed K892406: Modified oxygen delivery/CO 2 Sample Nasal Cannula Device description The proposed devices consist of a bifurcat… | 1989 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- 1 of the 2 ancestors has a recall of any class.
- 2 other devices also cite its predicate K863883.
How does its category compare?
All CCK devicesCCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.
FDA decisions per year · CCK
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · CCK
169in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · CCK
1in 2022
Class I (8 since 2007) Class II/III not classified
Adverse event reports per year · CCK
1,259in 2025
MAUDE reports naming product code CCK, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 5 | 56 | 0 | 7 |
| 2008 | 3 | 248 | 1 | 20 |
| 2009 | 3 | 101 | 19 | 21 |
| 2010 | 3 | 125 | 4 | 12 |
| 2011 | 2 | — | 14 | 18 |
| 2012 | 7 | 150 | 3 | 13 |
| 2013 | 4 | 132 | 2 (1) | 28 |
| 2014 | 9 | 166 | 0 | 51 |
| 2015 | 5 | 105 | 1 | 114 |
| 2016 | 2 | — | 0 | 88 |
| 2017 | 5 | 134 | 0 | 58 |
| 2018 | 6 | 296 | 5 | 63 |
| 2019 | 7 | 261 | 7 (7) | 141 |
| 2020 | 4 | 188 | 1 | 2,302 |
| 2021 | 4 | 227 | 0 | 2,272 |
| 2022 | 3 | 226 | 1 | 2,475 |
| 2023 | 4 | 555 | 0 | 1,637 |
| 2024 | 3 | 592 | 0 | 1,216 |
| 2025 | 3 | 169 | 0 | 1,259 |
| 2026 | 3 | 224 | 0 | — |
What is it indicated for?
The ETC0 2 Nasal Cannula is an adjunct to oxygen therapy with its primary function being that of delivering low flow oxygen, up to 4 Ulmin, to a patient while providing a means to sample expired gas- The target population is adult and pediatric patients.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K120518 · printed Nov 6, 2026
Cite this page
510(k) Report. “K120518: End Tidal CO2 Nasal Cannula.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K120518
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026